Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127025071 | 12702507 | 1 | I | 201605 | 20160624 | 20160831 | 20160831 | PER | US-JNJFOC-20160623811 | JANSSEN | 60.43 | YR | A | M | Y | 74.84000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127025071 | 12702507 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | 125261 | SOLUTION FOR INJECTION | |||||||||
127025071 | 12702507 | 2 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 0 | 5 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127025071 | 12702507 | 1 | Erythrodermic psoriasis |
127025071 | 12702507 | 2 | Headache |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127025071 | 12702507 | Inappropriate schedule of drug administration | |
127025071 | 12702507 | Off label use | |
127025071 | 12702507 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127025071 | 12702507 | 1 | 201605 | 0 | ||
127025071 | 12702507 | 2 | 2015 | 0 |